Structures of Protein Aggregates by Solid-State NMR
通过固态 NMR 分析蛋白质聚集体的结构
基本信息
- 批准号:7931186
- 负责人:
- 金额:$ 18.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAmyloidAnisotropyArgonBehaviorBindingBrainChadChemicalsChemistryCollaborationsCommunitiesComplexData AnalysesData SetDevelopmentDiagnosticDimerizationDiseaseElectron MicroscopyEventFluorescenceHuman ResourcesKineticsKnowledgeLabelLaboratoriesLecithinLiteratureMagicMaintenanceMass Spectrum AnalysisMeasurementMembraneMethodsMicellesModelingModificationMolecular ConformationMonitorMutationN-terminalNMR SpectroscopyOxygenParkinson DiseasePathologyPhage DisplayPhosphatidic AcidPhysiologic pulsePhysiologicalPreparationProteinsProtocols documentationPublic HealthRegulationReportingResearchResearch PersonnelResearch Project GrantsResolutionSamplingSedimentation processSideSignal TransductionSiteSodium Dodecyl SulfateSolidSolutionsSpecificitySpin LabelsStagingStreptococcus IgG Fc-binding proteinStressStretchingStructural ModelsStructureSurfaceSynaptic VesiclesTechniquesTechnologyTestingThioflavin TVariantVesicleWood materialalpha synucleinbasedesigndimerearly onsetendosulfineglobular proteinhuman diseaseimprovedin vitro Modelin vivoinstrumentationinterestlight scatteringmutantneuron developmentoxidationplanetary Atmosphereprogramsprotein aggregateprotein aggregationresearch studyscaffoldsmall moleculesolid statesolid state nuclear magnetic resonancetool
项目摘要
Description: The long-term objective of this research project is to develop a detailed atomic-resolution
structural and functional understanding of protein aggregation and fibrillation relevant to human disease,
principally with studies of alpha-synuclein. Wild type alpha-synuclein and its mutants (A30P, E46K and
A53T) associated with early-onset Parkinson's disease (PD) will be examined in several structural states,
including protofibrils, fibrils and membrane-associatedcomplexes. We propose that the chemical details of
these structures determine the natural physiological function of alpha-synuclein and, in the mutants or under
environmental stress, contribute to PD pathology. Moreover, we propose that conversion among several
structural states is an essential feature of synucleins; this structural plasticity is likely to be required for
neuronal development and maintenance. To examine these structures, magic-angle spinning (MAS) solid-
state NMR (SSNMR) experiments will be employed, elucidating details of covalent chemistry, conformation
and dynamics that are inaccessible to other experimental techniques. Complementary analysis and
characterization techniques will include kinetic measurements (by thioflavin T fluorescence, light scattering
and sedimentation analysis), high-resolution mass spectrometry, atomic force and electron microscopy,
solution NMR and phage display. We will leverage these technologies along with sample preparation and
isotopic labeling strategies to improve our understanding of protein aggregation relevant to disease in the
specific case of alpha-synuclein, including: (1) the fundamental biophysical principles of alpha-synuclein
aggregation and membrane association, (2) specific structural information that will enable rational design
strategies for small molecules that modulate alpha-synuclein function and/or serve as diagnostic tools for
PD, and (3) elucidation of specific structural interactions between alpha-synuclein and other brain proteins.
Relevance to public health: Alpha-synuclein is a central player in Parkinson's disease. The precise
relationships between alpha-synuclein structure and this disease are not yet well understood. Our proposed
studies aim to advance this fundamental knowledge, which will assist the broader research community in
developing improved diagnostic tools and therapies for Parkinson's disease.
描述:本研究项目的长期目标是开发详细的原子分辨率
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chad M Rienstra其他文献
Chad M Rienstra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chad M Rienstra', 18)}}的其他基金
Technologies for Solid-State NMR Data Collection
固态核磁共振数据采集技术
- 批准号:
10323285 - 财政年份:2021
- 资助金额:
$ 18.56万 - 项目类别:
Technologies for Solid-State NMR Data Collection
固态核磁共振数据采集技术
- 批准号:
10573327 - 财政年份:2021
- 资助金额:
$ 18.56万 - 项目类别:
Technologies for Solid-State NMR Data Collection
固态核磁共振数据采集技术
- 批准号:
10089601 - 财政年份:2021
- 资助金额:
$ 18.56万 - 项目类别:
Low Temperature Solid-State NMR Technologies for Protein Structure Determination
用于蛋白质结构测定的低温固态核磁共振技术
- 批准号:
8710289 - 财政年份:2013
- 资助金额:
$ 18.56万 - 项目类别:
Low Temperature Solid-State NMR Technologies for Protein Structure Determination
用于蛋白质结构测定的低温固态核磁共振技术
- 批准号:
8575754 - 财政年份:2013
- 资助金额:
$ 18.56万 - 项目类别:
相似国自然基金
基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
- 批准号:81870666
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
- 批准号:81601123
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
- 批准号:30971012
- 批准年份:2009
- 资助金额:35.0 万元
- 项目类别:面上项目
抗阿兹海默病Beta-Amyloid寡聚物单链可变区抗体的筛选及其动物试验
- 批准号:30570622
- 批准年份:2005
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Elucidating the function of a protective protein in a novel in vitro reconstitution system for disaggregation of ubiquitinated amyloid fibrils
阐明保护蛋白在新型体外重构系统中用于解聚泛素化淀粉样蛋白原纤维的功能
- 批准号:
24K10522 - 财政年份:2024
- 资助金额:
$ 18.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
新規amyloid-β抑制因子ILEIの減少に伴うアルツハイマー病リスクと分子制御機構の解析
新型β淀粉样蛋白抑制剂ILEI降低相关阿尔茨海默病风险及分子调控机制分析
- 批准号:
23K06805 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Extracting the detrimental effects of amyloid beta oligomer using contextual learning and controlling it with antagonist molecules
使用情境学习提取β淀粉样蛋白寡聚体的有害影响并用拮抗剂分子控制它
- 批准号:
23K06348 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of inhibitors for amyloid peptide aggregation based on peptidomimetics
基于拟肽的淀粉样肽聚集抑制剂的开发
- 批准号:
23K14318 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effect of abnormal beta-amyloid on Ca dynamics in neural cells
异常β-淀粉样蛋白对神经细胞钙动力学的影响
- 批准号:
23K14744 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of novel functions of presenilin in ApoE secretion and brain amyloid removal
阐明早老素在 ApoE 分泌和脑淀粉样蛋白去除中的新功能
- 批准号:
23KF0156 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease
淀粉样蛋白病理学和阿尔茨海默病中 ATP 的星形细胞胞吐作用
- 批准号:
10722422 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Probing Amyloid Fibril Self-Assembly with Network Hamiltonian Simulations in Explicit Space
用显式空间中的网络哈密顿模拟探测淀粉样蛋白原纤维的自组装
- 批准号:
10715891 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:














{{item.name}}会员




